CS Group (SX.PA) Fundamental Analysis & Valuation

EPA:SX • FR0007317813

Current stock price

11.5 EUR
-0.05 (-0.43%)
Last:

This SX.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. SX.PA Profitability Analysis

1.1 Basic Checks

  • In the past year SX was profitable.
  • In the past year SX had a positive cash flow from operations.
SX.PA Yearly Net Income VS EBIT VS OCF VS FCFSX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 10M -10M 20M -20M

1.2 Ratios

  • SX has a worse Return On Assets (0.29%) than 70.00% of its industry peers.
  • SX has a Return On Equity of 1.87%. This is in the lower half of the industry: SX underperforms 67.14% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 5.52%, SX is doing worse than 61.43% of the companies in the same industry.
Industry RankSector Rank
ROA 0.29%
ROE 1.87%
ROIC 5.52%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SX.PA Yearly ROA, ROE, ROICSX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 5 -5 10 -10

1.3 Margins

  • SX has a worse Profit Margin (0.45%) than 71.43% of its industry peers.
  • SX's Operating Margin of 4.86% is on the low side compared to the rest of the industry. SX is outperformed by 60.00% of its industry peers.
  • SX's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 65.47%, SX perfoms like the industry average, outperforming 52.86% of the companies in the same industry.
  • SX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.86%
PM (TTM) 0.45%
GM 65.47%
OM growth 3Y-27.8%
OM growth 5Y-4.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.21%
GM growth 5Y0.28%
SX.PA Yearly Profit, Operating, Gross MarginsSX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. SX.PA Health Analysis

2.1 Basic Checks

  • SX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, SX has about the same amount of shares outstanding.
  • SX has a better debt/assets ratio than last year.
SX.PA Yearly Shares OutstandingSX.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M
SX.PA Yearly Total Debt VS Total AssetsSX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 100M 200M 300M

2.2 Solvency

  • Based on the Altman-Z score of 1.15, we must say that SX is in the distress zone and has some risk of bankruptcy.
  • SX's Altman-Z score of 1.15 is on the low side compared to the rest of the industry. SX is outperformed by 78.57% of its industry peers.
  • SX has a debt to FCF ratio of 72.35. This is a negative value and a sign of low solvency as SX would need 72.35 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 72.35, SX is not doing good in the industry: 64.29% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 1.26 is on the high side and indicates that SX has dependencies on debt financing.
  • SX has a worse Debt to Equity ratio (1.26) than 81.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF 72.35
Altman-Z 1.15
ROIC/WACC0.65
WACC8.47%
SX.PA Yearly LT Debt VS Equity VS FCFSX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 20M -20M 40M 60M 80M

2.3 Liquidity

  • SX has a Current Ratio of 1.03. This is a normal value and indicates that SX is financially healthy and should not expect problems in meeting its short term obligations.
  • SX's Current ratio of 1.03 is on the low side compared to the rest of the industry. SX is outperformed by 68.57% of its industry peers.
  • SX has a Quick Ratio of 1.01. This is a normal value and indicates that SX is financially healthy and should not expect problems in meeting its short term obligations.
  • SX has a Quick ratio of 1.01. This is in the lower half of the industry: SX underperforms 65.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 1.01
SX.PA Yearly Current Assets VS Current LiabilitesSX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. SX.PA Growth Analysis

3.1 Past

  • SX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 129.61%, which is quite impressive.
  • Looking at the last year, SX shows a quite strong growth in Revenue. The Revenue has grown by 14.45% in the last year.
  • Measured over the past years, SX shows a small growth in Revenue. The Revenue has been growing by 6.11% on average per year.
EPS 1Y (TTM)129.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.97%
Revenue 1Y (TTM)14.45%
Revenue growth 3Y5.63%
Revenue growth 5Y6.11%
Sales Q2Q%13.97%

3.2 Future

  • Based on estimates for the next years, SX will show a very strong growth in Earnings Per Share. The EPS will grow by 197.44% on average per year.
  • Based on estimates for the next years, SX will show a quite strong growth in Revenue. The Revenue will grow by 17.81% on average per year.
EPS Next Y292.98%
EPS Next 2Y331.85%
EPS Next 3Y197.44%
EPS Next 5YN/A
Revenue Next Year20.77%
Revenue Next 2Y21.04%
Revenue Next 3Y17.81%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SX.PA Yearly Revenue VS EstimatesSX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
SX.PA Yearly EPS VS EstimatesSX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0.2 -0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

2

4. SX.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 230.00, SX can be considered very expensive at the moment.
  • SX's Price/Earnings ratio is a bit more expensive when compared to the industry. SX is more expensive than 71.43% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.87, SX is valued quite expensively.
  • With a Price/Forward Earnings ratio of 21.01, SX is valued on the expensive side.
  • Based on the Price/Forward Earnings ratio, SX is valued a bit more expensive than the industry average as 60.00% of the companies are valued more cheaply.
  • SX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 38.51, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 230
Fwd PE 21.01
SX.PA Price Earnings VS Forward Price EarningsSX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SX is valued a bit more expensive than the industry average as 62.86% of the companies are valued more cheaply.
  • Based on the Price/Free Cash Flow ratio, SX is valued a bit more expensive than 61.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 138.83
EV/EBITDA 13.3
SX.PA Per share dataSX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • SX's earnings are expected to grow with 197.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.79
PEG (5Y)N/A
EPS Next 2Y331.85%
EPS Next 3Y197.44%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. SX.PA Dividend Analysis

5.1 Amount

  • SX has a yearly dividend return of 0.35%, which is pretty low.
  • SX's Dividend Yield is comparable with the industry average which is at 2.70.
  • With a Dividend Yield of 0.35, SX pays less dividend than the S&P500 average, which is at 1.81.
Industry RankSector Rank
Dividend Yield 0.35%

5.2 History

  • The dividend of SX decreases each year by -30.50%.
Dividend Growth(5Y)-30.5%
Div Incr Years0
Div Non Decr Years0
SX.PA Yearly Dividends per shareSX.PA Yearly Dividends per shareYearly Dividends per share 2019 2022 0 0 0 0 0

5.3 Sustainability

DP0%
EPS Next 2Y331.85%
EPS Next 3Y197.44%
SX.PA Yearly Income VS Free CF VS DividendSX.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 0 10M -10M 20M -20M

More info and screens

Find the best dividend stocksShow peers with best dividend

SX.PA Fundamentals: All Metrics, Ratios and Statistics

CS Group

EPA:SX (4/28/2023, 7:00:00 PM)

11.5

-0.05 (-0.43%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap281.82M
Revenue(TTM)253.50M
Net Income(TTM)1.15M
Analysts40
Price Target11.73 (2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.35%
Yearly Dividend0.04
Dividend Growth(5Y)-30.5%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-49.55%
EPS NY rev (3m)-49.55%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.89%
Revenue NY rev (3m)1.89%
Valuation
Industry RankSector Rank
PE 230
Fwd PE 21.01
P/S 1.11
P/FCF 138.83
P/OCF 36.94
P/B 4.61
P/tB N/A
EV/EBITDA 13.3
EPS(TTM)0.05
EY0.43%
EPS(NY)0.55
Fwd EY4.76%
FCF(TTM)0.08
FCFY0.72%
OCF(TTM)0.31
OCFY2.71%
SpS10.34
BVpS2.5
TBVpS-1.42
PEG (NY)0.79
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 0.29%
ROE 1.87%
ROCE N/A
ROIC 5.52%
ROICexc 14.63%
ROICexgc N/A
OM 4.86%
PM (TTM) 0.45%
GM 65.47%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)7.22%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-12.05%
ROICexc growth 5Y-6.22%
OM growth 3Y-27.8%
OM growth 5Y-4.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.21%
GM growth 5Y0.28%
F-Score7
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF 72.35
Debt/EBITDA 6.86
Cap/Depr 61.62%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 177.29%
Current Ratio 1.03
Quick Ratio 1.01
Altman-Z 1.15
F-Score7
WACC8.47%
ROIC/WACC0.65
Cap/Depr(3y)49.78%
Cap/Depr(5y)164.32%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)129.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.97%
EPS Next Y292.98%
EPS Next 2Y331.85%
EPS Next 3Y197.44%
EPS Next 5YN/A
Revenue 1Y (TTM)14.45%
Revenue growth 3Y5.63%
Revenue growth 5Y6.11%
Sales Q2Q%13.97%
Revenue Next Year20.77%
Revenue Next 2Y21.04%
Revenue Next 3Y17.81%
Revenue Next 5YN/A
EBIT growth 1Y117.67%
EBIT growth 3Y-23.74%
EBIT growth 5Y1.54%
EBIT Next Year446.67%
EBIT Next 3Y102.83%
EBIT Next 5YN/A
FCF growth 1Y-90.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-71.27%
OCF growth 3YN/A
OCF growth 5YN/A

CS Group / SX.PA Fundamental Analysis FAQ

What is the fundamental rating for SX stock?

ChartMill assigns a fundamental rating of 3 / 10 to SX.PA.


Can you provide the valuation status for CS Group?

ChartMill assigns a valuation rating of 3 / 10 to CS Group (SX.PA). This can be considered as Overvalued.


What is the profitability of SX stock?

CS Group (SX.PA) has a profitability rating of 2 / 10.


Can you provide the financial health for SX stock?

The financial health rating of CS Group (SX.PA) is 2 / 10.


Can you provide the expected EPS growth for SX stock?

The Earnings per Share (EPS) of CS Group (SX.PA) is expected to grow by 292.98% in the next year.